Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian CancerChangxin Wan, Sarah J. Hill, Myles Brown et al.|Cancer Research|2020Cited by 215
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Kornélia Polyák, Hua‐Jun Wu et al.|Molecular Cell|2020Cited by 207
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Ramesh A. Shivdasani, Yotam Drier et al.|Nature Medicine|2019Cited by 185
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C. Watt, Shom Goel, Paloma Cejas et al.|Nature Cancer|2020Cited by 110
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3Marco Seehawer, Kornélia Polyák, Zheqi Li et al.|Nature Cell Biology|2024Cited by 45